Skip to content

AMGN vs MRK: Dividend Comparison

AMGN$458.43
Amgen Inc
Health Care
vs
MRK$143.37
Merck & Co., Inc.
Health Care

Dividend data as of

Amgen Inc (AMGN) and Merck & Co., Inc. (MRK) are both in the Health Care sector, making them natural rivals for dividend investors. Both stocks offer similar yields — AMGN at 2.17% and MRK at 2.33%. For dividend growth, AMGN leads with a 5-year CAGR of 7.1% versus MRK's 6.0%. Both stocks carry a "Safe" dividend safety rating. Both are classified as Dividend Contenders.

Verdict

Best for Income
MRK
Higher yield at 2.33%
Best for Growth
AMGN
5yr CAGR of 7.1%
Best for Safety
MRK
Lower payout ratio (3%)

Track AMGN and MRK in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$458.43
$143.37
Dividend Yield
2.17%
2.33%
Annual Dividend
$10.08
$3.40
5yr Div CAGR
7.1%
6.0%
3yr Div CAGR
5.3%
5.2%
Consecutive Years
13
15
Payout Ratio
57.62%
3.43%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$217/yr
$233/yr

Yield Analysis

AMGN
2.17%
MRK
2.33%

MRK yields 0.16% more than AMGN. In dollar terms, AMGN pays $10.08/share vs MRK's $3.40/share annually.

Dividend Growth

AMGN 5yr CAGR
7.1%
decelerating
MRK 5yr CAGR
6.0%
decelerating

AMGN: Dividend growth is slowing — the 3-year CAGR of 5.3% trails the 5-year rate of 7.1% and the 10-year rate of 9.5%.

MRK: Dividend growth is slowing — the 3-year CAGR of 5.2% trails the 5-year rate of 6.0% and the 10-year rate of 6.8%.

Dividend Safety

AMGN
Safe
Payout Ratio58%
MRK
Safe
Payout Ratio3%

AMGN: The payout ratio of 58% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 1.7x.

MRK: The payout ratio of 3% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 0.3x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
AMGN
MRK
$10,000
$217/yr
$233/yr
$50,000
$1,086/yr
$1,167/yr
$100,000
$2,171/yr
$2,333/yr

What does $10,000 buy in AMGN vs MRK today?

At $458.43 per share, $10,000 buys about 21.8 shares of Amgen Inc (AMGN). Each share pays $10.08 per year in dividends, so the position starts out generating roughly $220 per year — about $18 a month.

At $143.37 per share, $10,000 buys about 69.7 shares of Merck & Co., Inc. (MRK). Each share pays $3.40 per year in dividends, so the position starts out generating roughly $237 per year — about $20 a month.

MRK is the larger income stream from day one: $17 per year more on the same $10,000 invested.

What could $10,000 of AMGN or MRK income look like in 10 years?

Amgen Inc (AMGN) has raised its dividend about 7.1% a year over the past five years. If that pace held, the $217 per year that $10,000 generates today at the current 2.17% yield would reach $433 per year by 2036 — a 4.3% yield on the original cost.

Merck & Co., Inc. (MRK) has raised its dividend about 6.0% a year over the past five years. If that pace held, the $233 per year that $10,000 generates today at the current 2.33% yield would reach $418 per year by 2036 — a 4.2% yield on the original cost.

On those trailing rates, AMGN pays more in 2036: $433 versus $418 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would AMGN's dividend growth overtake MRK's higher yield?

Amgen Inc (AMGN) yields less today (2.17% vs 2.33%) but has grown its dividend faster — 7.1% vs 6.0% a year over the past five years. If both trends continued, a $10,000 position in AMGN would start out-earning the same position in MRK around 2033 (roughly 7 years from now), paying about $352 per year at the crossover. Before that point, MRK pays more each year; after it, the gap compounds in AMGN's favor.

Can AMGN and MRK afford their dividends?

Amgen Inc (AMGN) earns $17.25 per share against $10.08 paid out in dividends — 1.7x coverage (a 58% payout ratio).

Merck & Co., Inc. (MRK) earns $1.00 per share against $3.40 paid out in dividends — 0.3x coverage (a 3% payout ratio).

AMGN's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for MRK if earnings weaken.

Which fits an early-retirement income portfolio better, AMGN or MRK?

For income you need right now, Merck & Co., Inc. (MRK) leads: $100,000 invested today pays about $194 a month at the current 2.33% yield, versus $181 a month from Amgen Inc (AMGN) at 2.17%.

With a decade or more before the income is needed, AMGN's faster dividend growth (7.1% vs 6.0% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: AMGN has raised its dividend 13 consecutive years; MRK has raised its dividend 15 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $536/yr in AMGN vs $526/yr in MRK by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.